Intrinsiqs

Is Tonix Pharmaceuticals Holding Corp. overvalued?

Tonix Pharmaceuticals Holding Corp. (TNXP) — key valuation metrics and fundamentals.

No verdict
Price
$12.71
Fair value
Current P/E
Normal P/E
Market cap
$202.6M
Dividend yield
0.0%
Return on equity
-69.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares TNXP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.